103 related articles for article (PubMed ID: 1761357)
21. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation.
Sharma RK; Lake BG; Makowski R; Bradshaw T; Earnshaw D; Dale JW; Gibson GG
Eur J Biochem; 1989 Sep; 184(1):69-78. PubMed ID: 2776771
[TBL] [Abstract][Full Text] [Related]
22. Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-transcriptional levels by conditions resulting in interferon-alpha/beta induction.
Delaporte E; Renton KW
Life Sci; 1997; 60(10):787-96. PubMed ID: 9064483
[TBL] [Abstract][Full Text] [Related]
23. Effect of a single dose of inducers and inhibitors on the rate of synthesis of cytochromes and reductases in liver organelles.
Raw I; Rockwell P
Mol Cell Biochem; 1979 Dec; 28(1-3):7-16. PubMed ID: 119159
[TBL] [Abstract][Full Text] [Related]
24. Azalanstat (RS-21607), a lanosterol 14 alpha-demethylase inhibitor with cholesterol-lowering activity.
Burton PM; Swinney DC; Heller R; Dunlap B; Chiou M; Malonzo E; Haller J; Walker KA; Salari A; Murakami S
Biochem Pharmacol; 1995 Aug; 50(4):529-44. PubMed ID: 7646560
[TBL] [Abstract][Full Text] [Related]
25. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
Chang TK; Chen H; Waxman DJ
Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
[TBL] [Abstract][Full Text] [Related]
26. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
Abdulla D; Goralski KB; Renton KW
Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) by murine and human hepatic preparations.
Egorin MJ; Rosen DM; Wolff JH; Callery PS; Musser SM; Eiseman JL
Cancer Res; 1998 Jun; 58(11):2385-96. PubMed ID: 9622079
[TBL] [Abstract][Full Text] [Related]
28. Effects of ethinyl estradiol on hepatic microsomal proteins and the turnover of cytochrome P-450.
Mackinnon M; Sutherland E; Simon FR
J Lab Clin Med; 1977 Dec; 90(6):1096-106. PubMed ID: 925482
[TBL] [Abstract][Full Text] [Related]
29. Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase.
Vincent SH; Wang RW; Karanam BV; Klimko M; Alvaro R; Chiu SH
Biochem Pharmacol; 1991 May; 41(9):1325-30. PubMed ID: 1708254
[TBL] [Abstract][Full Text] [Related]
30. Hepatic biotransformation of docetaxel (Taxotere) in vitro: involvement of the CYP3A subfamily in humans.
Marre F; Sanderink GJ; de Sousa G; Gaillard C; Martinet M; Rahmani R
Cancer Res; 1996 Mar; 56(6):1296-302. PubMed ID: 8640817
[TBL] [Abstract][Full Text] [Related]
31. Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes.
Berthou F; Dreano Y; Belloc C; Kangas L; Gautier JC; Beaune P
Biochem Pharmacol; 1994 May; 47(10):1883-95. PubMed ID: 8204106
[TBL] [Abstract][Full Text] [Related]
32. Effects of 17beta-estradiol and testosterone on hepatic mRNA/protein levels and catalytic activities of CYP2M1, CYP2K1, and CYP3A27 in rainbow trout (Oncorhynchus mykiss).
Buhler DR; Miranda CL; Henderson MC; Yang YH; Lee SJ; Wang-Buhler JL
Toxicol Appl Pharmacol; 2000 Oct; 168(2):91-101. PubMed ID: 11032764
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of recombinant interferon alpha on constitutive and inducible cytochrome P450 isozymes in mouse liver.
Stanley LA; Adams DJ; Balkwill FR; Griffin D; Wolf CR
Biochem Pharmacol; 1991 Jul; 42(2):311-20. PubMed ID: 1859448
[TBL] [Abstract][Full Text] [Related]
34. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha.
Nadin L; Butler AM; Farrell GC; Murray M
Gastroenterology; 1995 Jul; 109(1):198-205. PubMed ID: 7797018
[TBL] [Abstract][Full Text] [Related]
35. p-Nitroanisole O-demethylation in perfused hamster liver. High rates of pentose cycle-independent mixed-function oxidation.
Reinke LA; Harmon T; Belinsky SA; Kauffman FC; Thurman RG
Biochem Pharmacol; 1984 Apr; 33(8):1315-21. PubMed ID: 6712737
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the catabolism of polychlorinated biphenyl-induced cytochrome P-448 by microsomal heme oxygenase, and the inhibition of delta-aminolevulinate dehydratase by polychlorinated biphenyls.
Maines MD
J Exp Med; 1976 Dec; 144(6):1509-19. PubMed ID: 826600
[TBL] [Abstract][Full Text] [Related]
37. Effect of acetone administration on renal, pulmonary and hepatic monooxygenase activities in hamster.
Menicagli S; Puccini P; Longo V; Gervasi PG
Toxicology; 1990 Nov; 64(2):141-53. PubMed ID: 2219136
[TBL] [Abstract][Full Text] [Related]
38. Species variation in the metabolic activation of paracetamol to toxic intermediates: role of cytochromes p-450 and p-448.
Ioannides C; Steele CM; Parke DV
Toxicol Lett; 1983 Apr; 16(1-2):55-61. PubMed ID: 6836614
[TBL] [Abstract][Full Text] [Related]
39. Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
Spaethe SM; Jollow DJ
Biochem Pharmacol; 1989 Jun; 38(12):2027-38. PubMed ID: 2742604
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cytochrome P4502E1 expression by organosulfur compounds allylsulfide, allylmercaptan and allylmethylsulfide in rats.
Kwak MK; Kim SG; Kwak JY; Novak RF; Kim ND
Biochem Pharmacol; 1994 Feb; 47(3):531-9. PubMed ID: 8117321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]